Department of Sports Medicine, Third Faculty of Medicine, Charles University of Prague, Ruska 87, Prague 10, Czech Republic.
Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E258-65. doi: 10.1152/ajpendo.00767.2009. Epub 2010 May 18.
The aim of this study was to evaluate the relative contributions of various hormones involved in the regulation of lipid mobilization in subcutaneous adipose tissue (SCAT) during exercise and to assess the impact of obesity on this regulation. Eight lean and eight obese men performed a 60-min cycle exercise bout at 50% of their peak oxygen uptake on two occasions: during intravenous infusion of octreotide (a somatostatin analog) or physiological saline (control condition). Lipolysis in SCAT was evaluated using in situ microdialysis. One microdialysis probe was perfused with the adrenergic blockers phentolamine and propranolol while another probe was perfused with the phosphodiesterase and adenosine receptor inhibitor aminophylline. Compared with the control condition, infusion of octreotide reduced plasma insulin levels in lean (from approximately 3.5 to 0.5 microU/ml) and in obese (from approximately 9 to 2 microU/ml), blunted the exercise-induced rise in plasma GH and epinephrine levels in both groups, and enhanced the exercise-induced natriuretic peptide (NP) levels in lean but not in obese subjects. In both groups, octreotide infusion resulted in higher exercise-induced increases in dialysate glycerol concentrations in the phentolamine-containing probe while no difference in lipolytic response was found in the aminophylline-containing probe. The results suggest that insulin antilipolytic action plays a role in the regulation of lipolysis during exercise in lean as well as in obese subjects. The octreotide-induced enhancement of exercise lipolysis in lean subjects was associated with an increased exercise-induced plasma NP response. Adenosine may contribute to the inhibition of basal lipolysis in both subject groups.
本研究旨在评估在运动过程中参与调节皮下脂肪组织(SCAT)脂解作用的各种激素的相对贡献,并评估肥胖对此调节的影响。八名瘦人和八名肥胖男性在两次不同的情况下进行了 60 分钟的 50%峰值摄氧量的自行车运动:在静脉输注奥曲肽(生长抑素类似物)或生理盐水(对照条件)期间。使用原位微透析评估 SCAT 的脂肪分解。一个微透析探针用肾上腺素能阻滞剂苯氧苄胺和普萘洛尔灌注,另一个探针用磷酸二酯酶和腺苷受体抑制剂氨茶碱灌注。与对照条件相比,奥曲肽输注降低了瘦组(从约 3.5 微升至 0.5 微升)和肥胖组(从约 9 微升至 2 微升)的血浆胰岛素水平,减弱了两组的运动诱导的血浆 GH 和肾上腺素水平升高,并增强了瘦组但不是肥胖组的运动诱导的利钠肽(NP)水平。在两组中,奥曲肽输注导致含苯氧苄胺探针中运动诱导的透析液甘油浓度升高,但在含氨茶碱探针中发现脂肪分解反应无差异。结果表明,胰岛素的抗脂解作用在瘦和肥胖受试者的运动过程中调节脂肪分解作用中发挥作用。奥曲肽诱导的瘦受试者运动性脂肪分解增强与运动诱导的血浆 NP 反应增加有关。腺苷可能有助于抑制两组受试者的基础脂肪分解。